Impact of Updated Diagnostic Criteria for Long QT Syndrome on Clinical Detection of Diseased Patients
Kenshi Hayashi(Kanazawa University), Masakazu Yamagishi, Noboru Fujino(Kanazawa University), Minoru Horie(Nagahama City Hospital), Yoko Imi-Hashida(Kanazawa University), Hideki Itoh(Shiga University of Medical Science), Hidekazu Ino(Kanazawa University), Masa‐aki Kawashiri(Kanazawa University), Yusuke Fujii(Shiga University of Medical Science), Takekatsu Saito(Kanazawa University), Tetsuo Konno(Kanazawa University), Hayato Tada(Kanazawa University), Yoshihiro Tanaka(Kanazawa University), Toyonobu Tsuda(Kanazawa University), Kunio Ohta(Kanazawa University)
Cited by 14
Related Papers
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death
|Nature Genetics|2013|550
Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β
|Journal of Clinical Investigation|2010|440
T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity
|Clinical Science|2003|313
T‐peak to T‐end interval may be a better predictor of high‐risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin i mutation than qt dispersion
|Clinical Cardiology|2002|267
Collagen remodelling in myocardia of patients with diabetes.
|Journal of Clinical Pathology|1993|247